Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015 (2015), Article ID 832057, 14 pages
http://dx.doi.org/10.1155/2015/832057
Review Article

Extracellular Vesicles: Role in Inflammatory Responses and Potential Uses in Vaccination in Cancer and Infectious Diseases

1Laboratório de Imunologia Celular e Bioquímica de Fungos e Protozoários, Departamento de Ciências Biológicas, Universidade Federal de São Paulo (UNIFESP), Campus Diadema, 09913-030 São Paulo, SP, Brazil
2Laboratório de Parasitologia Celular e Molecular, Centro de Pesquisas René Rachou, Fundação Oswaldo Cruz, 30190-002 Belo Horizonte, MG, Brazil

Received 24 October 2014; Accepted 21 February 2015

Academic Editor: Aldo Tagliabue

Copyright © 2015 João Henrique Campos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Kourembanas, “Exosomes: vehicles of intercellular signaling, biomarkers, and vectors of cell therapy,” Annual Review of Physiology, vol. 77, no. 1, pp. 13–27, 2015. View at Publisher · View at Google Scholar
  2. C. Théry, M. Ostrowski, and E. Segura, “Membrane vesicles as conveyors of immune responses,” Nature Reviews Immunology, vol. 9, no. 8, pp. 581–593, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Théry, L. Zitvogel, and S. Amigorena, “Exosomes: Composition, biogenesis and function,” Nature Reviews Immunology, vol. 2, no. 8, pp. 569–579, 2002. View at Google Scholar · View at Scopus
  4. M. Colombo, G. Raposo, and C. Théry, “Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles,” Annual Review of Cell and Developmental Biology, vol. 30, no. 1, pp. 255–289, 2014. View at Publisher · View at Google Scholar
  5. B. L. Deatheragea and B. T. Cooksona, “Membrane vesicle release in bacteria, eukaryotes, and archaea: a conserved yet underappreciated aspect of microbial life,” Infection and Immunity, vol. 80, no. 6, pp. 1948–1957, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. J. B. le Pecq, “Dexosomes as a therapeutic cancer vaccine: from bench to bedside,” Blood Cells, Molecules, and Diseases, vol. 35, no. 2, pp. 129–135, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Stegmayr and G. Ronquist, “Promotive effect on human sperm progressive motility by prostasomes,” Urological Research, vol. 10, no. 5, pp. 253–257, 1982. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Tanimura, D. H. McGregor, and H. C. Anderson, “Matrix vesicles in atherosclerotic calcification,” Proceedings of the Society for Experimental Biology and Medicine, vol. 172, no. 2, pp. 173–177, 1983. View at Publisher · View at Google Scholar · View at Scopus
  9. G. F. V. Mollard, G. A. Mignery, M. Baumert et al., “rab3 is a small GTP-binding protein exclusively localized to synaptic vesicles,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 5, pp. 1988–1992, 1990. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Mathivanan, H. Ji, and R. J. Simpson, “Exosomes: extracellular organelles important in intercellular communication,” Journal of Proteomics, vol. 73, no. 10, pp. 1907–1920, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. Z. Andreu and M. Yanez-Mo, “Tetraspanins in extracellular vesicle formation and function,” Frontiers in Immunology, vol. 5, p. 442, 2014. View at Google Scholar
  12. S. Mathivanan, C. J. Fahner, G. E. Reid, and R. J. Simpson, “ExoCarta 2012: database of exosomal proteins, RNA and lipids,” Nucleic Acids Research, vol. 40, no. 1, pp. D1241–D1244, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. J. Martínez-Lorenzo, A. Anel, S. Gamen et al., “Activated human T cells release bioactive Fas ligand and APO2 ligand in microvesicles,” Journal of Immunology, vol. 163, no. 3, pp. 1274–1281, 1999. View at Google Scholar · View at Scopus
  14. S. J. Germain, G. P. Sacks, S. R. Soorana, I. L. Sargent, and C. W. Redman, “Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles,” Journal of Immunology, vol. 178, no. 9, pp. 5949–5956, 2007. View at Google Scholar · View at Scopus
  15. M. Messerli, K. May, S. R. Hansson et al., “Feto-maternal interactions in pregnancies: placental microparticles activate peripheral blood monocytes,” Placenta, vol. 31, no. 2, pp. 106–112, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Al-Nedawi, B. Meehan, J. Micallef et al., “Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells,” Nature Cell Biology, vol. 10, no. 5, pp. 619–624, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. J. N. Higginbotham, M. Demory Beckler, J. D. Gephart et al., “Amphiregulin exosomes increase cancer cell invasion,” Current Biology, vol. 21, no. 9, pp. 779–786, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Théry, L. Duban, E. Segura, P. Væron, O. Lantz, and S. Amigorena, “Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes,” Nature Immunology, vol. 3, no. 12, pp. 1156–1162, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Wei, X. Lai, S. Yu et al., “Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells,” Breast Cancer Research and Treatment, vol. 147, no. 2, pp. 423–431, 2014. View at Publisher · View at Google Scholar
  20. W. Zhou, M. Y. Fong, Y. Min et al., “Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis,” Cancer Cell, vol. 25, no. 4, pp. 501–515, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Wang, C. Zhao, H. Shi et al., “Deregulated microRNAs in gastric cancer tissue-derived mesenchymal stem cells: novel biomarkers and a mechanism for gastric cancer,” British Journal of Cancer, vol. 110, no. 5, pp. 1199–1210, 2014. View at Publisher · View at Google Scholar
  22. K. Valencia, D. Luis-Ravelo, N. Bovy et al., “MiRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization,” Molecular Oncology, vol. 8, no. 3, pp. 689–703, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Chen, Y. Zhang, and X. Wu, “786-0 renal cancer cell line-derived exosomes promote 786-0 cell migration and invasion in vitro,” Oncology Letters, vol. 7, no. 5, pp. 1576–1580, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. C. M. Wilson, T. Naves, F. Vincent et al., “Sortilin mediates the release and transfer of exosomes in concert with two tyrosine kinase receptors,” Journal of Cell Science, vol. 127, part 18, pp. 3983–3997, 2014. View at Publisher · View at Google Scholar
  25. T. Wang, D. M. Gilkes, N. Takano et al., “Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 31, pp. E3234–E3242, 2014. View at Publisher · View at Google Scholar
  26. K. Ohshima, K. Kanto, K. Hatakeyama et al., “Exosome-mediated extracellular release of polyadenylate-binding protein 1 in human metastatic duodenal cancer cells,” Proteomics, vol. 14, no. 20, pp. 2297–2306, 2014. View at Publisher · View at Google Scholar
  27. T. Liu, D. E. Mendes, and C. E. Berkman, “Functional prostate-specific membrane antigen is enriched in exosomes from prostate cancer cells,” International Journal of Oncology, vol. 44, no. 3, pp. 918–922, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Viaud, S. Ploix, V. Lapierre et al., “Updated technology to produce highly immunogenic dendritic cell-derived exosomes of clinical grade: a critical role of interferon-γ,” Journal of Immunotherapy, vol. 34, no. 1, pp. 65–75, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. W. Li, D. Mu, F. Tian et al., “Exosomes derived from Rab27aoverexpressing tumor cells elicit efficient induction of antitumor immunity,” Molecular Medicine Reports, vol. 8, no. 6, pp. 1876–1882, 2013. View at Google Scholar
  30. D. Bottero, M. E. Gaillard, A. Errea et al., “Outer membrane vesicles derived from Bordetella parapertussis as an acellular vaccine against Bordetella parapertussis and Bordetella pertussis infection,” Vaccine, vol. 31, no. 45, pp. 5262–5268, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Yaron, G. L. Kolling, L. Simon, and K. R. Matthews, “Vesicle-mediated transfer of virulence genes from Escherichia coli O157:H7 to other enteric bacteria,” Applied and Environmental Microbiology, vol. 66, no. 10, pp. 4414–4420, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. J. L. Kadurugamuwa and T. J. Beveridge, “Virulence factors are released from Pseudomonas aeruginosa in association with membrane vesicles during normal growth and exposure to gentamicin: a novel mechanism of enzyme secretion,” Journal of Bacteriology, vol. 177, no. 14, pp. 3998–4008, 1995. View at Google Scholar · View at Scopus
  33. H. M. Kulkarni and M. V. Jagannadham, “Biogenesis and multifaceted roles of outer membrane vesicles from Gram-negative bacteria,” Microbiology, vol. 160, part 10, pp. 2109–2121, 2014. View at Publisher · View at Google Scholar
  34. E.-Y. Lee, D.-S. Choi, K.-P. Kim, and Y. S. Gho, “Proteomics in gram-negative bacterial outer membrane vesicles,” Mass Spectrometry Reviews, vol. 27, no. 6, pp. 535–555, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. I. C. Almeida and R. T. Gazzinelli, “Proinflammatory activity of glycosylphosphatidylinositol anchors derived from Trypanosoma cruzi: structural and functional analyses,” Journal of Leukocyte Biology, vol. 70, no. 4, pp. 467–477, 2001. View at Google Scholar · View at Scopus
  36. M. H. Magdesian, R. Giordano, H. Ulrich et al., “Infection by Trypanosoma cruzi: identification of a parasite ligand and its host cell receptor,” The Journal of Biological Chemistry, vol. 276, no. 22, pp. 19382–19389, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. J. M. Silverman, J. Clos, E. Horakova et al., “Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells,” The Journal of Immunology, vol. 185, no. 9, pp. 5011–5022, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. J. M. Silverman and N. E. Reiner, “Leishmania exosomes deliver preemptive strikes to create an environment permissive for early infection,” Frontiers in Cellular and Infection Microbiology, vol. 1, article 26, 2011. View at Publisher · View at Google Scholar
  39. R. R. de Assis, I. C. Ibraim, P. M. Nogueira, R. P. Soares, and S. J. Turco, “Glycoconjugates in New World species of Leishmania: polymorphisms in lipophosphoglycan and glycoinositolphospholipids and interaction with hosts,” Biochimica et Biophysica Acta—General Subjects, vol. 1820, no. 9, pp. 1354–1365, 2012. View at Publisher · View at Google Scholar · View at Scopus
  40. M. F. Goncalves, E. S. Umezawa, A. M. Katzin et al., “Trypanosoma cruzi: shedding of surface antigens as membrane vesicles,” Experimental Parasitology, vol. 72, no. 1, pp. 43–53, 1991. View at Publisher · View at Google Scholar · View at Scopus
  41. A. C. Trocoli Torrecilhas, R. R. Tonelli, W. R. Pavanelli et al., “Trypanosoma cruzi: parasite shed vesicles increase heart parasitism and generate an intense inflammatory response,” Microbes and Infection, vol. 11, no. 1, pp. 29–39, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. M. C. Vallejo, A. L. Matsuo, L. Ganiko et al., “The pathogenic fungus Paracoccidioides brasiliensis exports extracellular vesicles containing highly Immunogenic α-galactosyl epitopes,” Eukaryotic Cell, vol. 10, no. 3, pp. 343–351, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. O. Zaragoza, M. L. Rodrigues, M. De Jesus, S. Frases, E. Dadachova, and A. Casadevall, “The capsule of the fungal pathogen Cryptococcus neoformans,” Advances in Applied Microbiology, vol. 68, pp. 133–216, 2009. View at Publisher · View at Google Scholar
  44. F. L. Fonseca, L. L. Nohara, R. J. B. Cordero et al., “Immunomodulatory effects of serotype B glucuronoxylomannan from Cryptococcus gattii correlate with polysaccharide diameter,” Infection and Immunity, vol. 78, no. 9, pp. 3861–3870, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. M. L. Rodrigues, L. Nimrichter, R. J. Cordero, and A. Casadevall, “Fungal polysaccharides: biological activity beyond the usual structural properties,” Frontiers in Microbiology, vol. 2, article 171, 2011. View at Google Scholar
  46. S. Atay, S. Banskota, J. Crow, G. Sethi, L. Rink, and A. K. Godwin, “Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 2, pp. 711–716, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. W.-X. Chen, Y.-Q. Cai, M.-M. Lv et al., “Exosomes from docetaxel-resistant breast cancer cells alter chemosensitivity by delivering microRNAs,” Tumor Biology, vol. 35, no. 10, pp. 9649–9659, 2014. View at Publisher · View at Google Scholar
  48. X. Xiao, S. Yu, S. Li et al., “Exosomes: decreased sensitivity of lung cancer A549 cells to cisplatin,” PLoS ONE, vol. 9, no. 2, Article ID e89534, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. C. Corcoran, S. Rani, and L. O'Driscoll, “miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression,” The Prostate, vol. 74, no. 13, pp. 1320–1334, 2014. View at Publisher · View at Google Scholar
  50. K. Takahashi, I. K. Yan, T. Kogure, H. Haga, and T. Patel, “Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer,” FEBS Open Bio, vol. 4, pp. 458–467, 2014. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Chen, J. Guo, M. Yang, X. Zhu, and X. Cao, “Chemokine-containing exosomes are released from heat-stressed tumor cells via lipid raft-dependent pathway and act as efficient tumor vaccine,” Journal of Immunology, vol. 186, no. 4, pp. 2219–2228, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Dutta, C. Warshall, C. Bandyopadhyay, D. Dutta, and B. Chandran, “Interactions between exosomes from breast cancer cells and primary mammary epithelial cells leads to generation of reactive oxygen species which induce DNA damage response, stabilization of p53 and autophagy in epithelial cells,” PLoS ONE, vol. 9, no. 5, Article ID e97580, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Liu, H. Sun, X. Wang et al., “Increased exosomal microRNA-21 and microRNA-146a levels in the cervicovaginal lavage specimens of patients with cervical cancer,” International Journal of Molecular Sciences, vol. 15, no. 1, pp. 758–773, 2014. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. J. Jiang and D. D. Bikle, “LncRNA: a new player in 1alpha, 25(OH)2 vitamin D3/VDR protection against skin cancer formation,” Experimental Dermatology, vol. 23, no. 3, pp. 147–150, 2014. View at Publisher · View at Google Scholar
  55. C. Kahlert, S. A. Melo, A. Protopopov et al., “Identification of doublestranded genomic dna spanning all chromosomes with mutated KRAS and P53 DNA in the serum exosomes of patients with pancreatic cancer,” Journal of Biological Chemistry, vol. 289, no. 7, pp. 3869–3875, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. T. J. Smyth, J. S. Redzic, M. W. Graner, and T. J. Anchordoquy, “Examination of the specificity of tumor cell derived exosomes with tumor cells in vitro,” Biochimica et Biophysica Acta—Biomembranes, vol. 1838, no. 11, pp. 2954–2965, 2014. View at Publisher · View at Google Scholar
  57. K. Shimbo, S. Miyaki, H. Ishitobi et al., “Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration,” Biochemical and Biophysical Research Communications, vol. 445, no. 2, pp. 381–387, 2014. View at Publisher · View at Google Scholar
  58. A. Riches, E. Campbell, E. Borger, and S. Powis, “Regulation of exosome release from mammary epithelial and breast cancer cells—a new regulatory pathway,” European Journal of Cancer, vol. 50, no. 5, pp. 1025–1034, 2014. View at Publisher · View at Google Scholar · View at Scopus
  59. H. M. Hosseini, A. A. I. Fooladi, J. Soleimanirad, M. R. Nourani, S. Davaran, and M. Mahdavi, “Staphylococcal entorotoxin B anchored exosome induces apoptosis in negative esterogen receptor breast cancer cells,” Tumor Biology, vol. 35, no. 4, pp. 3699–3707, 2014. View at Publisher · View at Google Scholar · View at Scopus
  60. H. Mahmoodzadeh Hosseini, A. Ali Imani Fooladi, J. Soleimanirad, M. Reza Nourani, and M. Mahdavi, “Exosome/staphylococcal enterotoxin B, an anti tumor compound against pancreatic cancer,” Journal of B.U.ON., vol. 19, no. 2, pp. 440–448, 2014. View at Google Scholar
  61. D. D. Taylor and C. Gercel-Taylor, “The origin, function, and diagnostic potential of RNA within extracellular vesicles present in human biological fluids,” Frontiers in Genetics, vol. 4, article 142, 2013. View at Publisher · View at Google Scholar · View at Scopus
  62. Y. Yao, L. Chen, W. Wei, X. Deng, L. Ma, and S. Hao, “Tumor cell-derived exosome-targeted dendritic cells stimulate stronger CD8+ CTL responses and antitumor immunities,” Biochemical and Biophysical Research Communications, vol. 436, no. 1, pp. 60–65, 2013. View at Publisher · View at Google Scholar · View at Scopus
  63. T. I. Näslund, U. Gehrmann, K. R. Qazi, M. C. I. Karlsson, and S. Gabrielsson, “Dendritic cell-derived exosomes need to activate both T and B Cells to induce antitumor immunity,” Journal of Immunology, vol. 190, no. 6, pp. 2712–2719, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. T. I. Näslund, U. Gehrmann, and S. Gabrielsson, “Cancer immunotherapy with exosomes requires B-cell activation,” OncoImmunology, vol. 2, no. 6, Article ID e24533, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. D.-H. Hsu, P. Paz, G. Villaflor et al., “Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides,” Journal of Immunotherapy, vol. 26, no. 5, pp. 440–450, 2003. View at Publisher · View at Google Scholar · View at Scopus
  66. C. Sedlik, J. Vigneron, L. Torrieri-Dramard et al., “Different immunogenicity but similar antitumor efficacy of two DNA vaccines coding for an antigen secreted in different membrane vesicle-associated forms,” Journal of Extracellular Vesicles, vol. 3, Article ID 24646, 2014. View at Publisher · View at Google Scholar
  67. J. L. Baker, L. Chen, J. A. Rosenthal, D. Putnam, and M. P. DeLisa, “Microbial biosynthesis of designer outer membrane vesicles,” Current Opinion in Biotechnology, vol. 29, no. 1, pp. 76–84, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. D. Mayrand and D. Grenier, “Biological activities of outer membrane vesicles,” Canadian Journal of Microbiology, vol. 35, no. 6, pp. 607–613, 1989. View at Publisher · View at Google Scholar · View at Scopus
  69. A. J. Manning and M. J. Kuehn, “Functional advantages conferred by extracellular prokaryotic membrane vesicles,” Journal of Molecular Microbiology and Biotechnology, vol. 23, no. 1-2, pp. 131–141, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. D. W. Dorward and C. F. Garon, “DNA is packaged within membrane-derived vesicles of gram-negative but not gram-positive bacteria,” Applied and Environmental Microbiology, vol. 56, no. 6, pp. 1960–1962, 1990. View at Google Scholar · View at Scopus
  71. E.-Y. Lee, D.-Y. Choi, D.-K. Kim et al., “Gram-positive bacteria produce membrane vesicles: proteomics-based characterization of Staphylococcus aureus-derived membrane vesicles,” Proteomics, vol. 9, no. 24, pp. 5425–5436, 2009. View at Publisher · View at Google Scholar · View at Scopus
  72. S.-H. Kim, K.-S. Kim, S.-R. Lee et al., “Structural modifications of outer membrane vesicles to refine them as vaccine delivery vehicles,” Biochimica et Biophysica Acta—Biomembranes, vol. 1788, no. 10, pp. 2150–2159, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. N. C. Kesty and M. J. Kuehn, “Incorporation of heterologous outer membrane and periplasmic proteins into Escherichia coli outer membrane vesicles,” The Journal of Biological Chemistry, vol. 279, no. 3, pp. 2069–2076, 2004. View at Publisher · View at Google Scholar · View at Scopus
  74. N. C. Kesty, K. M. Mason, M. Reedy, S. E. Miller, and M. J. Kuehn, “Enterotoxigenic Escherichia coli vesicles target toxin delivery into mammalian cells,” The EMBO Journal, vol. 23, no. 23, pp. 4538–4549, 2004. View at Publisher · View at Google Scholar · View at Scopus
  75. S. J. Bauman and M. J. Kuehn, “Pseudomonas aeruginosa vesicles associate with and are internalized by human lung epithelial cells,” BMC Microbiology, vol. 9, article 26, 2009. View at Publisher · View at Google Scholar · View at Scopus
  76. S. J. Bauman and M. J. Kuehn, “Purification of outer membrane vesicles from Pseudomonas aeruginosa and their activation of an IL-8 response,” Microbes and Infection, vol. 8, no. 9-10, pp. 2400–2408, 2006. View at Publisher · View at Google Scholar · View at Scopus
  77. R. Fiocca, V. Necchi, P. Sommi et al., “Release of Helicobacter pylori vacuolating cytotoxin by both a specific secretion pathway and budding of outer membrane vesicles. Uptake of released toxin and vesicles by gastric epithelium,” The Journal of Pathology, vol. 188, no. 2, pp. 220–226, 1999. View at Publisher · View at Google Scholar
  78. M. L. Rodrigues, E. S. Nakayasu, D. L. Oliveira et al., “Extracellular vesicles produced by Cryptococcus neoformans contain protein components associated with virulence,” Eukaryotic Cell, vol. 7, no. 1, pp. 58–67, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. M. L. Rodrigues, L. Nimrichter, D. L. Oliveira et al., “Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport,” Eukaryotic Cell, vol. 6, no. 1, pp. 48–59, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. A. Kulp and M. J. Kuehn, “Biological Functions and biogenesis of secreted bacterial outer membrane vesicles,” Annual Review of Microbiology, vol. 64, pp. 163–184, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. E. van der Pol, A. N. Böing, P. Harrison, A. Sturk, and R. Nieuwland, “Classification, functions, and clinical relevance of extracellular vesicles,” Pharmacological Reviews, vol. 64, no. 3, pp. 676–705, 2012. View at Publisher · View at Google Scholar · View at Scopus
  82. R. Acevedo, S. Fernández, C. Zayas et al., “Bacterial outer membrane vesicles and vaccine applications,” Frontiers in Immunology, vol. 5, article 121, 2014. View at Publisher · View at Google Scholar · View at Scopus
  83. J. Rivera, R. J. B. Cordero, A. S. Nakouzi, S. Frases, A. Nicola, and A. Casadevall, “Bacillus anthracis produces membrane-derived vesicles containing biologically active toxins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 44, pp. 19002–19007, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. L. Mashburn-Warren, R. J. C. Mclean, and M. Whiteley, “Gram-negative outer membrane vesicles: beyond the cell surface,” Geobiology, vol. 6, no. 3, pp. 214–219, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. C. W. Choi, E. C. Park, S. H. Yun et al., “Proteomic characterization of the outer membrane vesicle of Pseudomonas putida KT2440,” Journal of Proteome Research, vol. 13, no. 10, pp. 4298–4309, 2014. View at Google Scholar
  86. E. Altindis, Y. Fu, and J. J. Mekalanos, “Proteomic analysis of Vibrio cholerae outer membrane vesicles,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 15, pp. E1548–E1556, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. J. C. Kouokam, S. N. Wai, M. Fällman, U. Dobrindt, J. Hacker, and B. E. Uhlin, “Active cytotoxic necrotizing factor 1 associated with outer membrane vesicles from uropathogenic Escherichia coli,” Infection and Immunity, vol. 74, no. 4, pp. 2022–2030, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. E. Bartolini, E. Ianni, E. Frigimelica et al., “Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro,” Journal of Extracellular Vesicles, vol. 2, 2013. View at Publisher · View at Google Scholar
  89. M. R. Aghasadeghi, A. S. Salmani, S. M. Sadat et al., “Application of outer membrane vesicle of Neisseria meningitidis serogroup B as a new adjuvant to induce strongly Th1-oriented responses against HIV-1,” Current HIV Research, vol. 9, no. 8, pp. 630–635, 2011. View at Publisher · View at Google Scholar · View at Scopus
  90. J. K. Schnitzer, S. Berzel, M. Fajardo-Moser, K. A. Remer, and H. Moll, “Fragments of antigen-loaded dendritic cells (DC) and DC-derived exosomes induce protective immunity against Leishmania major,” Vaccine, vol. 28, no. 36, pp. 5785–5793, 2010. View at Publisher · View at Google Scholar · View at Scopus
  91. L. Ramachandra, Y. Qu, Y. Wang et al., “Mycobacterium tuberculosis synergizes with ATP to induce release of microvesicles and exosomes containing major histocompatibility complex class II molecules capable of antigen presentation,” Infection and Immunity, vol. 78, no. 12, pp. 5116–5125, 2010. View at Publisher · View at Google Scholar · View at Scopus
  92. A. Moshiri, A. Dashtbani-Roozbehani, S. N. Peerayeh, and S. D. Siadat, “Outer membrane vesicle: a macromolecule with multifunctional activity,” Human Vaccines and Immunotherapeutics, vol. 8, no. 7, pp. 953–955, 2012. View at Publisher · View at Google Scholar · View at Scopus
  93. S. W. Sharpe, M. J. Kuehn, and K. M. Mason, “Elicitation of epithelial cell-derived immune effectors by outer membrane vesicles of nontypeable Haemophilus influenzae,” Infection and Immunity, vol. 79, no. 11, pp. 4361–4369, 2011. View at Publisher · View at Google Scholar · View at Scopus
  94. D. Ren, K. L. Nelson, P. N. Uchakin, A. L. Smith, X.-X. Gu, and D. A. Daines, “Characterization of extended co-culture of non-typeable Haemophilus influenzae with primary human respiratory tissues,” Experimental Biology and Medicine, vol. 237, no. 5, pp. 540–547, 2012. View at Publisher · View at Google Scholar · View at Scopus
  95. T. J. Beveridge, “Structures of gram-negative cell walls and their derived membrane vesicles,” Journal of Bacteriology, vol. 181, no. 16, pp. 4725–4733, 1999. View at Google Scholar · View at Scopus
  96. M. J. Kuehn and N. C. Kesty, “Bacterial outer membrane vesicles and the host-pathogen interaction,” Genes and Development, vol. 19, no. 22, pp. 2645–2655, 2005. View at Publisher · View at Google Scholar · View at Scopus
  97. K. Zhao, X. Deng, C. He, B. Yue, and M. Wu, “Pseudomonas aeruginosa outer membrane vesicles modulate host immune responses by targeting the toll-like receptor 4 signaling pathway,” Infection and Immunity, vol. 81, no. 12, pp. 4509–4518, 2013. View at Publisher · View at Google Scholar · View at Scopus
  98. F. Deknuydt, T. Nordström, and K. Riesbeck, “Diversion of the host humoral response: A novel virulence mechanism of Haemophilus influenzae mediated via outer membrane vesicles,” Journal of Leukocyte Biology, vol. 95, no. 6, pp. 983–991, 2014. View at Publisher · View at Google Scholar · View at Scopus
  99. O. Rossi, I. Pesce, C. Giannelli et al., “Modulation of endotoxicity of Shigella generalized modules for membrane antigens (GMMA) by genetic lipid A modifications: relative activation of TLR4 and TLR2 pathways in different mutants,” The Journal of Biological Chemistry, vol. 289, no. 36, pp. 24922–24935, 2014. View at Publisher · View at Google Scholar
  100. P. Freixeiro, E. Diéguez-Casal, L. Costoya et al., “Study of the stability of proteoliposomes as vehicles for vaccines against Neisseria meningitidis based on recombinant porin complexes,” International Journal of Pharmaceutics, vol. 443, no. 1-2, pp. 1–8, 2013. View at Publisher · View at Google Scholar · View at Scopus
  101. V. Delbos, L. Lemée, J. Bénichou et al., “Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage,” Vaccine, vol. 31, no. 40, pp. 4416–4420, 2013. View at Publisher · View at Google Scholar · View at Scopus
  102. H. Sjursen, E. Wedege, E. Rosenqvist et al., “IgG subclass antibodies to serogroup B meningococcal outer membrane antigens following infection and vaccination,” APMIS, vol. 98, no. 12, pp. 1061–1069, 1990. View at Publisher · View at Google Scholar · View at Scopus
  103. J. Holst, P. Oster, R. Arnold et al., “Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future,” Human Vaccines and Immunotherapeutics, vol. 9, no. 6, pp. 1241–1253, 2013. View at Publisher · View at Google Scholar · View at Scopus
  104. G. Bjune, E. A. Hoiby, J. K. Gronnesby et al., “Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway,” The Lancet, vol. 338, no. 8775, pp. 1093–1096, 1991. View at Publisher · View at Google Scholar · View at Scopus
  105. M. Sadarangani and A. J. Pollard, “Serogroup B meningococcal vaccines-an unfinished story,” The Lancet Infectious Diseases, vol. 10, no. 2, pp. 112–124, 2010. View at Publisher · View at Google Scholar · View at Scopus
  106. F. Caron, I. P. du Châtelet, J.-P. Leroy et al., “From tailor-made to ready-to-wear meningococcal B vaccines: longitudinal study of a clonal meningococcal B outbreak,” The Lancet Infectious Diseases, vol. 11, no. 6, pp. 455–463, 2011. View at Publisher · View at Google Scholar · View at Scopus
  107. P. van der Ley and G. van den Dobbelsteen, “Next-generation outer membrane vesicle vaccines against Neisseria meningitidis based on nontoxic LPS mutants,” Human Vaccines, vol. 7, no. 8, pp. 886–890, 2011. View at Publisher · View at Google Scholar · View at Scopus
  108. O. Y. Kim, B. S. Hong, K.-S. Park et al., “Immunization with Escherichia coli outer membrane vesicles protects bacteria-induced lethality via Th1 and Th17 cell responses,” The Journal of Immunology, vol. 190, no. 8, pp. 4092–4102, 2013. View at Publisher · View at Google Scholar · View at Scopus
  109. M. J. Rodríguez-Ortega, N. Norais, G. Bensi et al., “Characterization and identification of vaccine candidate proteins through analysis of the group A Streptococcus surface proteome,” Nature Biotechnology, vol. 24, no. 2, pp. 191–197, 2006. View at Publisher · View at Google Scholar · View at Scopus
  110. M.-R. Kim, S.-W. Hong, E.-B. Choi et al., “Staphylococcus aureus-derived extracellular vesicles induce neutrophilic pulmonary inflammation via both Th1 and Th17 cell responses,” Allergy, vol. 67, no. 10, pp. 1271–1281, 2012. View at Publisher · View at Google Scholar · View at Scopus
  111. A. Marcilla, L. Martin-Jaular, M. Trelis et al., “Extracellular vesicles in parasitic diseases,” Journal of Extracellular Vesicles, vol. 3, Article ID 25040, 2014. View at Publisher · View at Google Scholar
  112. A. Cronemberger-Andrade, L. Aragão-França, C. F. de Araujo et al., “Extracellular vesicles from leishmania-infected macrophages confer an anti-infection cytokine-production profile to naïve macrophages,” PLoS Neglected Tropical Diseases, vol. 8, no. 9, p. e3161, 2014. View at Publisher · View at Google Scholar
  113. E. Bayer-Santos, C. Aguilar-Bonavides, S. P. Rodrigues et al., “Proteomic analysis of trypanosoma cruzi secretome: characterization of two populations of extracellular vesicles and soluble proteins,” Journal of Proteome Research, vol. 12, no. 2, pp. 883–897, 2013. View at Publisher · View at Google Scholar · View at Scopus
  114. A. C. Torrecilhas, R. I. Schumacher, M. J. M. Alves, and W. Colli, “Vesicles as carriers of virulence factors in parasitic protozoan diseases,” Microbes and Infection, vol. 14, no. 15, pp. 1465–1474, 2012. View at Publisher · View at Google Scholar · View at Scopus
  115. I. Cestari, E. Ansa-Addo, P. Deolindo, J. M. Inal, and M. I. Ramirez, “Trypanosoma cruzi immune evasion mediated by host cell-derived microvesicles,” Journal of Immunology, vol. 188, no. 4, pp. 1942–1952, 2012. View at Publisher · View at Google Scholar · View at Scopus
  116. A. Geiger, C. Hirtz, T. Bécue et al., “Exocytosis and protein secretion in Trypanosoma,” BMC Microbiology, vol. 10, article 20, 2010. View at Publisher · View at Google Scholar · View at Scopus
  117. F. M. Campos, B. S. Franklin, A. Teixeira-Carvalho et al., “Augmented plasma microparticles during acute Plasmodium vivax infection,” Malaria Journal, vol. 9, article 327, 2010. View at Publisher · View at Google Scholar · View at Scopus
  118. P. Y. Mantel, A. N. Hoang, I. Goldowitz et al., “Malaria-infected erythrocyte-derived microvesicles mediate cellular communication within the parasite population and with the host immune system,” Cell Host and Microbe, vol. 13, no. 5, pp. 521–534, 2013. View at Publisher · View at Google Scholar · View at Scopus
  119. O. Twu, N. de Miguel, G. Lustig et al., “Trichomonas vaginalis exosomes deliver cargo to host cells and mediate host:parasite interactions,” PLoS Pathogens, vol. 9, no. 7, Article ID e1003482, 2013. View at Publisher · View at Google Scholar · View at Scopus
  120. S. Bhatnagar, K. Shinagawa, F. J. Castellino, and J. S. Schorey, “Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo,” Blood, vol. 110, no. 9, pp. 3234–3244, 2007. View at Publisher · View at Google Scholar · View at Scopus
  121. C. Beauvillain, S. Ruiz, R. Guiton, D. Bout, and I. Dimier-Poisson, “A vaccine based on exosomes secreted by a dendritic cell line confers protection against T. gondii infection in syngeneic and allogeneic mice,” Microbes and Infection, vol. 9, no. 14-15, pp. 1614–1622, 2007. View at Publisher · View at Google Scholar · View at Scopus
  122. C. Beauvillain, M. O. Juste, S. Dion, J. Pierre, and I. Dimier-Poisson, “Exosomes are an effective vaccine against congenital toxoplasmosis in mice,” Vaccine, vol. 27, no. 11, pp. 1750–1757, 2009. View at Publisher · View at Google Scholar · View at Scopus
  123. E. del Cacho, M. Gallego, S. H. Lee et al., “Induction of protective immunity against Eimeria tenella, Eimeria maxima, and Eimeria acervulina infections using dendritic cell-derived exosomes,” Infection and Immunity, vol. 80, no. 5, pp. 1909–1916, 2012. View at Publisher · View at Google Scholar · View at Scopus
  124. D. Bernal, M. Trelis, S. Montaner et al., “Surface analysis of Dicrocoelium dendriticum. The molecular characterization of exosomes reveals the presence of miRNAs,” Journal of Proteomics, vol. 105, pp. 232–241, 2014. View at Publisher · View at Google Scholar · View at Scopus
  125. J. R. Coura, “Chagas disease: control, elimination and eradication. Is it possible?” Memorias do Instituto Oswaldo Cruz, vol. 108, no. 8, pp. 962–967, 2013. View at Publisher · View at Google Scholar · View at Scopus
  126. I. C. Almeida, M. M. Camargo, D. O. Procópio et al., “Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents,” The EMBO Journal, vol. 19, no. 7, pp. 1476–1485, 2000. View at Publisher · View at Google Scholar · View at Scopus
  127. M. A. J. Ferguson, “The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research,” Journal of Cell Science, vol. 112, no. 17, pp. 2799–2809, 1999. View at Google Scholar · View at Scopus
  128. M. A. S. Campos, I. C. Almeida, O. Takeuchi et al., “Activation of toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite,” Journal of Immunology, vol. 167, no. 1, pp. 416–423, 2001. View at Publisher · View at Google Scholar · View at Scopus
  129. D. Golgher and R. T. Gazzinelli, “Innate and acquired immunity in the pathogenesis of Chagas disease,” Autoimmunity, vol. 37, no. 5, pp. 399–409, 2004. View at Publisher · View at Google Scholar · View at Scopus
  130. R. P. Soares, A. C. Torrecilhas, R. R. Assis et al., “Intraspecies variation in Trypanosoma cruzi GPI-mucins: biological activities and differential expression of alpha-galactosyl residues,” The American Journal of Tropical Medicine and Hygiene, vol. 87, no. 1, pp. 87–96, 2012. View at Publisher · View at Google Scholar · View at Scopus
  131. I. C. Almeida, M. A. J. Ferguson, S. Schenkman, and L. R. Travassos, “Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas' disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi,” Biochemical Journal, vol. 304, no. 3, pp. 793–802, 1994. View at Google Scholar · View at Scopus
  132. C. Serna, J. A. Lara, S. P. Rodrigues, A. F. Marques, I. C. Almeida, and R. A. Maldonado, “A synthetic peptide from Trypanosoma cruzi mucin-like associated surface protein as candidate for a vaccine against Chagas disease,” Vaccine, vol. 32, no. 28, pp. 3525–3532, 2014. View at Publisher · View at Google Scholar · View at Scopus
  133. U. Lambertz, J. M. Silverman, D. Nandan et al., “Secreted virulence factors and immune evasion in visceral leishmaniasis,” Journal of Leukocyte Biology, vol. 91, no. 6, pp. 887–899, 2012. View at Publisher · View at Google Scholar · View at Scopus
  134. J. M. Silverman and N. E. Reiner, “Exosomes and other microvesicles in infection biology: organelles with unanticipated phenotypes,” Cellular Microbiology, vol. 13, no. 1, pp. 1–9, 2011. View at Publisher · View at Google Scholar · View at Scopus
  135. C. E. Wylie, M. Carbonell-Antoñanzas, E. Aiassa et al., “A systematic review of the efficacy of prophylactic control measures for naturally-occurring canine leishmaniosis, part I: vaccinations,” Preventive Veterinary Medicine, vol. 117, no. 1, pp. 7–18, 2014. View at Publisher · View at Google Scholar
  136. O. Twu, N. de Miguel, G. Lustig et al., “Trichomonas vaginalis exosomes deliver cargo to host cells and mediate host: parasite interactions,” PLoS Pathogens, vol. 9, no. 7, Article ID e1003482, 2013. View at Publisher · View at Google Scholar · View at Scopus
  137. L. Martin-Jaular, E. S. Nakayasu, M. Ferrer, I. C. Almeida, and H. A. del Portillo, “Exosomes from Plasmodium yoelii-infected reticulocytes protect mice from lethal infections,” PLoS ONE, vol. 6, no. 10, Article ID e26588, 2011. View at Publisher · View at Google Scholar · View at Scopus
  138. N. Regev-Rudzki, D. W. Wilson, T. G. Carvalho et al., “Cell-cell communication between malaria-infected red blood cells via exosome-like vesicles,” Cell, vol. 153, no. 5, pp. 1120–1133, 2013. View at Publisher · View at Google Scholar · View at Scopus
  139. C. A. Hunter and L. D. Sibley, “Modulation of innate immunity by Toxoplasma gondii virulence effectors,” Nature Reviews Microbiology, vol. 10, no. 11, pp. 766–778, 2012. View at Publisher · View at Google Scholar · View at Scopus
  140. B. J. C. Quah and H. C. O'Neill, “The immunogenicity of dendritic cell-derived exosomes,” Blood Cells, Molecules, and Diseases, vol. 35, no. 2, pp. 94–110, 2005. View at Publisher · View at Google Scholar · View at Scopus
  141. I. Bourguin, M. Moser, D. Buzoni-Gatel et al., “Murine dendritic cells pulsed in vitro with Toxoplasma gondii antigens induce protective immunity in vivo,” Infection and Immunity, vol. 66, no. 10, pp. 4867–4874, 1998. View at Google Scholar · View at Scopus
  142. F. Aline, D. Bout, S. Amigorena, P. Roingeard, and I. Dimier-Poisson, “Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection,” Infection and Immunity, vol. 72, no. 7, pp. 4127–4137, 2004. View at Publisher · View at Google Scholar · View at Scopus
  143. E. del Cacho, M. Gallego, S. H. Lee et al., “Induction of protective immunity against Eimeria tenella infection using antigen-loaded dendritic cells (DC) and DC-derived exosomes,” Vaccine, vol. 29, no. 21, pp. 3818–3825, 2011. View at Publisher · View at Google Scholar · View at Scopus
  144. E. del Cacho, M. Gallego, H. S. Lillehoj, J. Quilez, E. P. Lillehoj, and C. Sánchez-Acedo, “Tetraspanin-3 regulates protective immunity against Eimeria tenella infection following immunization with dendritic cell-derived exosomes,” Vaccine, vol. 31, no. 41, pp. 4668–4674, 2013. View at Publisher · View at Google Scholar · View at Scopus
  145. S. L. Newman and A. G. Smulian, “Iron uptake and virulence in Histoplasma capsulatum,” Current Opinion in Microbiology, vol. 16, no. 6, pp. 700–707, 2013. View at Publisher · View at Google Scholar · View at Scopus
  146. I. Bartha and J. Fellay, “Adaptation on a genomic scale,” eLife, vol. 4, Article ID e06193, 2015. View at Publisher · View at Google Scholar
  147. M. L. Rodrigues, E. S. Nakayasu, I. C. Almeida, and L. Nimrichter, “The impact of proteomics on the understanding of functions and biogenesis of fungal extracellular vesicles,” Journal of Proteomics, vol. 97, pp. 177–186, 2014. View at Publisher · View at Google Scholar · View at Scopus
  148. A. Casadevall, J. D. Nosanchuk, P. Williamson, and M. L. Rodrigues, “Vesicular transport across the fungal cell wall,” Trends in Microbiology, vol. 17, no. 4, pp. 158–162, 2009. View at Publisher · View at Google Scholar · View at Scopus
  149. S. J. Free, “Fungal Cell Wall Organization and Biosynthesis,” Advances in Genetics, vol. 81, pp. 33–82, 2013. View at Publisher · View at Google Scholar · View at Scopus
  150. D. L. Oliveira, C. G. Freire-de-Lima, J. D. Nosanchuk, A. Casadevall, M. L. Rodrigues, and L. Nimrichter, “Extracellular vesicles from Cryptococcus neoformans modulate macrophage functions,” Infection and Immunity, vol. 78, no. 4, pp. 1601–1609, 2010. View at Publisher · View at Google Scholar · View at Scopus
  151. G. Vargas, J. D. B. Rocha, D. L. Oliveira et al., “Compositional and immunobiological analyses of extracellular vesicles released by Candida albicans,” Cellular Microbiology, vol. 17, no. 3, pp. 389–407, 2015. View at Publisher · View at Google Scholar
  152. M. L. Rodrigues, L. Shi, E. Barreto-Bergter et al., “Monoclonal antibody to fungal glucosylceramide protects mice against lethal Cryptococcus neoformans infection,” Clinical and Vaccine Immunology, vol. 14, no. 10, pp. 1372–1376, 2007. View at Publisher · View at Google Scholar · View at Scopus
  153. P. C. Albuquerque, E. S. Nakayasu, M. L. Rodrigues et al., “Vesicular transport in Histoplasma capsulatum: an effective mechanism for trans-cell wall transfer of proteins and lipids in ascomycetes,” Cellular Microbiology, vol. 10, no. 8, pp. 1695–1710, 2008. View at Publisher · View at Google Scholar · View at Scopus
  154. D. L. Oliveira, E. S. Nakayasu, L. S. Joffe et al., “Characterization of yeast extracellular vesicles: evidence for the participation of different pathways of cellular traffic in vesicle biogenesis,” PLoS ONE, vol. 5, no. 6, Article ID e11113, 2010. View at Publisher · View at Google Scholar · View at Scopus
  155. M. C. Vallejo, E. S. Nakayasu, L. V. G. Longo et al., “Lipidomic analysis of extracellular vesicles from the pathogenic phase of Paracoccidioides brasiliensis,” PLoS ONE, vol. 7, no. 6, Article ID e39463, 2012. View at Publisher · View at Google Scholar · View at Scopus
  156. M. C. Vallejo, E. S. Nakayasu, A. L. Matsuo et al., “Vesicle and vesicle-free extracellular proteome of Paracoccidioides brasiliensis: comparative analysis with other pathogenic fungi,” Journal of Proteome Research, vol. 11, no. 3, pp. 1676–1685, 2012. View at Publisher · View at Google Scholar · View at Scopus
  157. D. L. Oliveira, L. Nimrichter, K. Miranda et al., “Cryptococcus neoformans cryoultramicrotomy and vesicle fractionation reveals an intimate association between membrane lipids and glucuronoxylomannan,” Fungal Genetics and Biology, vol. 46, no. 12, pp. 956–963, 2009. View at Publisher · View at Google Scholar · View at Scopus
  158. H. C. Eisenman, S. Frases, A. M. Nicola, M. L. Rodrigues, and A. Casadevall, “Vesicle-associated melanization in Cryptococcus neoformans,” Microbiology, vol. 155, part 12, pp. 3860–3867, 2009. View at Publisher · View at Google Scholar · View at Scopus
  159. P. C. Albuquerque, R. J. B. Cordero, F. L. Fonseca et al., “A Paracoccidioides brasiliensis glycan shares serologic and functional properties with cryptococcal glucuronoxylomannan,” Fungal Genetics and Biology, vol. 49, no. 11, pp. 943–954, 2012. View at Publisher · View at Google Scholar · View at Scopus
  160. L. Nimrichter and M. L. Rodrigues, “Fungal glucosylceramides: from structural components to biologically active targets of new antimicrobials,” Frontiers in Microbiology, vol. 2, article 212, 2011. View at Publisher · View at Google Scholar · View at Scopus
  161. M. S. Toledo, E. Suzuki, S. B. Levery, A. H. Straus, and H. K. Takahashi, “Characterization of monoclonal antibody MEST-2 specific to glucosylceramide of fungi and plants,” Glycobiology, vol. 11, no. 2, pp. 105–112, 2001. View at Publisher · View at Google Scholar · View at Scopus
  162. M. L. Rodrigues, L. R. Travassos, K. R. Miranda et al., “Human antibodies against a purified glucosylceramide from Cryptococcus neoformans inhibit cell budding and fungal growth,” Infection and Immunity, vol. 68, no. 12, pp. 7049–7060, 2000. View at Publisher · View at Google Scholar · View at Scopus
  163. P. C. Rittershaus, T. B. Kechichian, J. C. Allegood et al., “Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans,” The Journal of Clinical Investigation, vol. 116, no. 6, pp. 1651–1659, 2006. View at Publisher · View at Google Scholar · View at Scopus
  164. S. M. Noble, S. French, L. A. Kohn, V. Chen, and A. D. Johnson, “Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity,” Nature Genetics, vol. 42, no. 7, pp. 590–598, 2010. View at Publisher · View at Google Scholar · View at Scopus
  165. L. L. Guimaraes, M. S. Toledo, F. A. S. Ferreira, A. H. Straus, and H. K. Takahashi, “Structural diversity and biological significance of glycosphingolipids in pathogenic and opportunistic fungi,” Frontiers in Cellular and Infection Microbiology, vol. 4, article 138, 2014. View at Publisher · View at Google Scholar
  166. L. A. Albacker, V. Chaudhary, Y.-J. Chang et al., “Invariant natural killer T cells recognize a fungal glycosphingolipid that can induce airway hyperreactivity,” Nature Medicine, vol. 19, no. 10, pp. 1297–1304, 2013. View at Publisher · View at Google Scholar · View at Scopus
  167. J. Garcia-Rivera, H. C. Eisenman, J. D. Nosanchuk et al., “Comparative analysis of Cryptococcus neoformans acid-resistant particles generated from pigmented cells grown in different laccase substrates,” Fungal Genetics and Biology, vol. 42, no. 12, pp. 989–998, 2005. View at Publisher · View at Google Scholar · View at Scopus
  168. C. P. Taborda, M. B. da Silva, J. D. Nosanchuk, and L. R. Travassos, “Melanin as a virulence factor of Paracoccidioides brasiliensis and other dimorphic pathogenic fungi: a minireview,” Mycopathologia, vol. 165, no. 4-5, pp. 331–339, 2008. View at Publisher · View at Google Scholar · View at Scopus
  169. Y. Wang, P. Aisen, and A. Casadevall, “Cryptococcus neoformans melanin and virulence: mechanism of action,” Infection and Immunity, vol. 63, no. 8, pp. 3131–3136, 1995. View at Google Scholar · View at Scopus
  170. Á. L. Rosas, J. D. Nosanchuk, M. Feldmesser, G. M. Cox, H. C. McDade, and A. Casadevall, “Synthesis of polymerized melanin by Cryptococcus neoformans in infected rodents,” Infection and Immunity, vol. 68, no. 5, pp. 2845–2853, 2000. View at Publisher · View at Google Scholar · View at Scopus
  171. M. B. da Silva, A. F. Marques, J. D. Nosanchuk, A. Casadevall, L. R. Travassos, and C. P. Taborda, “Melanin in the dimorphic fungal pathogen Paracoccidioides brasiliensis: effects on phagocytosis, intracellular resistance and drug susceptibility,” Microbes and Infection, vol. 8, no. 1, pp. 197–205, 2006. View at Publisher · View at Google Scholar · View at Scopus
  172. D. Van Duin, A. Casadevall, and J. D. Nosanchuk, “Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin,” Antimicrobial Agents and Chemotherapy, vol. 46, no. 11, pp. 3394–3400, 2002. View at Publisher · View at Google Scholar · View at Scopus
  173. M. Zhang and R. Schekman, “Cell biology: unconventional secretion, unconventional solutions,” Science, vol. 340, no. 6132, pp. 559–561, 2013. View at Publisher · View at Google Scholar · View at Scopus